{"id":"NCT00384176","sponsor":"AstraZeneca","briefTitle":"First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX","officialTitle":"A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-08-30","primaryCompletion":"2009-11-15","completion":"2015-08-19","firstPosted":"2006-10-05","resultsPosted":"2012-11-28","lastUpdate":"2017-04-14"},"enrollment":1814,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"Cediranib","otherNames":["RECENTIN™","AZD2171"]},{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin®"]},{"type":"DRUG","name":"5-fluorouracil ( in FOLFOX)","otherNames":["5-FU"]},{"type":"DRUG","name":"Leucovorin (in FOLFOX)","otherNames":[]},{"type":"DRUG","name":"Oxaliplatin (in FOLFOX)","otherNames":["Eloxatin®"]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to see if Cediranib in combination with FOLFOX is effective in treating metastatic colorectal cancer and to see how it compares with Avastin (Bevacizumab) in combination with FOLFOX.","primaryOutcome":{"measure":"Progression Free Survival","timeFrame":"Baseline then at Weeks 8, 16, 24 and then every 12 weeks until progression","effectByArm":[{"arm":"Cediranib 20 mg","deltaMin":9.9,"sd":null},{"arm":"Bevacizumab 5 mg/kg","deltaMin":10.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":280,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Egypt","Finland","France","Germany","Hungary","India","Israel","Italy","Latvia","Malta","Philippines","Poland","Russia","Slovakia","South Africa","Spain","Taiwan","Thailand","Turkey (Türkiye)","Ukraine","United Kingdom","Vietnam"]},"refs":{"pmids":["31378656","30679026","19203899"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=417&filename=CSR-D8480C00013.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":275,"n":705},"commonTop":["Diarrhoea","Nausea","Fatigue","Neutropenia","Hypertension"]}}